1. Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population
   Nataliya Babyshkina et al, 2014, Medical Oncology CrossRef
2. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis
   Min Huang et al, 2020, Cancer Research CrossRef
3. Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
   Matthew G. Davey et al, 2022, BJS Open CrossRef
4. Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
   Paul Baron et al, 2016, Annals of Surgical Oncology CrossRef
5. Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
   null null et al, 2016, Annals of Surgical Oncology CrossRef
6. Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
   Siew Kuan Lim et al, 2016, Cancer Research and Treatment CrossRef
7. Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
   Laura M. Spring et al, 2020, Clinical Cancer Research CrossRef
8. Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer
   Carlos A. Huertas-Caro et al, 2023, Scientific Reports CrossRef
9. Assessment of the Predictive Role of Ki-67 in Breast Cancer Patients’ Responses to Neoadjuvant Chemotherapy
   Ghizlane Rais et al, 2024, European Journal of Breast Health CrossRef
10. Sentinel lymph nodes for breast carcinoma: an update on current practice
    Aoife Maguire et al, 2016, Histopathology CrossRef